Literature DB >> 30185366

Upper extremity venous thrombosis associated with primary antiphospholipid syndrome and immunoglobulin M nephropathy in diabetes mellitus type II.

Can Hüzmeli1, Ferhan Candan1, Ayşe Şeker Koçkara1, Demet Alaygut2, Mansur Kayataş1.   

Abstract

Antiphospholipid syndrome (APS) is a disorder characterized by antiphospholipid antibody positivity, arterial or venous thrombosis, and fetal loss. In APS, renal as well as vascular and glomerular involvement is observed. Systemic lupus erythematosus and other connective tissue diseases should be excluded to diagnose primary APS. Immunoglobulin M (IgM) nephropathy is characterized by single or dominant IgM deposition in glomerular mesangium. It often presents with hematuria and proteinuria. In a 45-year-old female patient admitted to our clinic with diabetes mellitus and proteinuria, fundus examination did not reveal diabetic retinopathy but a high anticardiolipin IgM and venous thrombosis in the upper extremity were observed. Renal biopsy revealed IgM nephropathy. The patient was diagnosed with primary APS and IgM nephropathy. Cyclophosphamide and steroid treatment was started. Her proteinuria decreased as a result of the treatment. Although, it is reported in the literature that primary APS coexists with other glomerulonephritis, we did not detect coexistence of primary APS and IgM nephropathy.

Entities:  

Year:  2015        PMID: 30185366      PMCID: PMC6072689          DOI: 10.5152/eurjrheum.2015.0109

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  10 in total

1.  Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease.

Authors:  T J Hendra; E Baguley; E N Harris; M H Khamashta; R C Trembath; G R Hughes; J S Yudkin
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  Pauci-immune glomerulonephritis associated with primary antiphospholipid syndrome.

Authors:  Fatih Dede; Yasin Simsek; Ali Riza Odabas; Deniz Ayli; Mansur Kayatas
Journal:  Rheumatol Int       Date:  2007-09-27       Impact factor: 2.631

3.  Nehprotic syndrome with glomerular mesangial IgM deposits.

Authors:  A H Cohen; W A Border; R J Glassock
Journal:  Lab Invest       Date:  1978-05       Impact factor: 5.662

4.  Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.

Authors:  Ilhan Tarkun; Abdullah Hacihanefioğlu; Pinar Tarkun; Berrin Cetinarslan; Zeynep Cantürk
Journal:  Diabetes Res Clin Pract       Date:  2005-06       Impact factor: 5.602

5.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

6.  Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?

Authors:  F Galtier-Dereure; C Biron; M Vies; V Bourgeois; J F Schved; J Bringer
Journal:  Lupus       Date:  1998       Impact factor: 2.911

Review 7.  The expanding spectrum of renal diseases associated with antiphospholipid syndrome.

Authors:  Fadi Fakhouri; Laure-Hélène Noël; Julien Zuber; Hélène Beaufils; Frank Martinez; Pierre Lebon; Thomas Papo; Dominique Chauveau; Olivier Bletry; Jean-Pierre Grünfeld; Jean-Charles Piette; Philippe Lesavre
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

8.  Non-diabetic renal diseases in a multi-ethnic New Zealand cohort with type 2 diabetes mellitus: clinical and histopathological features.

Authors:  L Jonathan Zwi; Theodora S Y Yiu; Mark R Marshall; Michael K Lam-Po-Tang
Journal:  Pathology       Date:  2014-08       Impact factor: 5.306

9.  Anticardiolipin antibodies in patients with type 2 diabetes mellitus.

Authors:  José María Calvo-Romero; Esther María Lima-Rodríguez
Journal:  Clin Med Res       Date:  2009-02-26

10.  Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes.

Authors:  Ja Min Byun; Cheol Hyun Lee; Sul Ra Lee; Ju Young Moon; Sang Ho Lee; Tae Won Lee; Chun Gyoo Ihm; Kyung Hwan Jeong
Journal:  Korean J Intern Med       Date:  2013-08-14       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.